Advanced search
Publication Cover
Journal of Investigative Surgery Volume 26, 2013 - Issue 6
Submit an article Journal homepage
534
Views
12
CrossRef citations to date
0
Altmetric
NEW METHODOLOGIES

Comparison of Two Syngeneic Orthotopic Murine Models of Pancreatic Adenocarcinoma

Mehrdad Nikfarjam Department of Surgery, Austin Health, University of Melbourne, Austin Health, LTB8, Heidleberg, Victoria, Australia,Correspondence[email protected]
,
Dannel Yeo Department of Surgery, Austin Health, University of Melbourne, Austin Health, LTB8, Heidleberg, Victoria, Australia,
,
Hong He Austin Health, University of Melbourne, Heidleberg, Victoria, Australia
,
Graham Baldwin Austin Health, University of Melbourne, Heidleberg, Victoria, Australia
,
Theodora Fifis Austin Health, University of Melbourne, Heidleberg, Victoria, Australia
,
Patricia Costa Austin Health, University of Melbourne, Heidleberg, Victoria, Australia
,
Bryan Tan Austin Health, University of Melbourne, Heidleberg, Victoria, Australia
,
Eunice Yang Austin Health, University of Melbourne, Heidleberg, Victoria, Australia
,
Shu wen wen Austin Health, University of Melbourne, Heidleberg, Victoria, Australia
&
Christopher Christophi Austin Health, University of Melbourne, Heidleberg, Victoria, Australia
 show all
Pages 352-359 | Received 20 Jan 2013, Accepted 25 Mar 2013, Published online: 19 Aug 2013

REFERENCES

  • Vincent A, Herman J, Schulick R, Pancreatic cancer. Lancet. 2011;378:607–620.
  • Jemal A, Siegel R, Xu J, Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300.
  • Winter JM, Brennan MF, Tang LH, Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades. Ann Surg Oncol. 2012;19:169–175.
  • Hoffman RM. Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest New Drugs. 1999;17:343–359.
  • Erkan M, Hausmann S, Michalski CW, The role of stroma in pancreatic cancer: diagnostic and therapeutic implications. Nat Rev Gastroenterol Hepatol. 2012;9: 454–467.
  • Li X, Ma Q, Xu Q, Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment. Curr Pharm Des. 2012;18:2404–2415.
  • Capella G, Farre L, Villanueva A, Orthotopic models of human pancreatic cancer. Ann N Y Acad Sci. 1999;880:103–109.
  • Fogh J, Orfeo T, Tiso J, Twenty-three new human tumor lines established in nude mice. Exp Cell Biol. 1980;48:229–239.
  • Ding Y, Cravero JD, Adrian K, Modeling pancreatic cancer in vivo: from xenograft and carcinogen-induced systems to genetically engineered mice. Pancreas. 2010;39:283–292.
  • Olive KP, Tuveson DA. The use of targeted mouse models for preclinical testing of novel cancer therapeutics. Clin Cancer Res. 2006;12:5277–5287.
  • Hassanin H, Serba S, Schmidt J, Ex vivo expanded telomerase-specific T cells are effective in an orthotopic mouse model for pancreatic adenocarcinoma. Clin Exp Immunol. 2009;158:125–132.
  • Hotz HG, Hines OJ, Foitzik T, Animal models of exocrine pancreatic cancer. Int J Colorectal Dis. 2000;15:136–143.
  • Westphalen CB, Olive KP. Genetically engineered mouse models of pancreatic cancer. Cancer J. 2012;18: 502–510.
  • Schmidt M, Deschner EE, Thaler HT, Gastrointestinal cancer studies in the human to nude mouse heterotransplant system. Gastroenterology. 1977;72:829–837.
  • Dineen SP, Sullivan LA, Beck AW, The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer. BMC Cancer. 2008;8:352.
  • Partecke LI, Sendler M, Kaeding A, A syngeneic orthotopic murine model of pancreatic adenocarcinoma in the C57/BL6 mouse using the Panc02 and 6606PDA cell lines. Eur Surg Res. 2011;47:98–107.
  • Fidler IJ. Modulation of the organ microenvironment for treatment of cancer metastasis. J Natl Cancer Inst. 1995;87:1588–1592.
  • Tseng WW, Winer D, Kenkel JA, Development of an orthotopic model of invasive pancreatic cancer in an immunocompetent murine host. Clin Cancer Res. 2010;16:3684–3695.
  • Bibby MC. Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages. Eur J Cancer. 2004;40:852–857.
  • Partecke IL, Kaeding A, Sendler M, In vivo imaging of pancreatic tumours and liver metastases using 7 Tesla MRI in a murine orthotopic pancreatic cancer model and a liver metastases model. BMC Cancer. 2011;11:40.
  • Ishizu K, Sunose N, Yamazaki K, Development and characterization of a model of liver metastasis using human colon cancer HCT-116 cells. Biol Pharm Bull. 2007;30:1779–1783.
  • Marincola FM, Drucker BJ, Siao DY, The nude mouse as a model for the study of human pancreatic cancer. J Surg Res. 1989;47:520–529.
  • Alves F, Contag S, Missbach M, An orthotopic model of ductal adenocarcinoma of the pancreas in severe combined immunodeficient mice representing all steps of the metastatic cascade. Pancreas. 2001;23:227–235.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.